Stati Uniti - inglese - NLM (National Library of Medicine)

contract pharmacy services-pa - clonazepam (unii: 5pe9fde8gb) (clonazepam - unii:5pe9fde8gb) - clonazepam is useful alone or as an adjunct in the treatment of the lennox-gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. in patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful. in some studies, up to 30% of patients have shown a loss of anticonvulsant activity, often within 3 months of administration. in some cases, dosage adjustment may reestablish efficacy. clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in dsm-v. panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. the efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the dsm-iiir category of panic disorder (see

Stati Uniti - inglese - NLM (National Library of Medicine)

contract pharmacy services-pa - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride tablets are indicated for the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses ( see warnings), reserve tramadol hydrochloride tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: - have not been tolerated, or are not expected to be tolerated. - have not provided adequate analgesia, or are not expected to provide adequate analgesia. tramadol hydrochloride tablets contraindicated in patients with: - significant respiratory depression ( see warnings). - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment ( see warnings). - known or suspected gastrointestinal obstruction, including paralytic ileus ( see warnings). - hypersensitivity to tramadol

Stati Uniti - inglese - NLM (National Library of Medicine)

humana pharmacy, inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine 100mg - injection (depot) - 100 mg/0.5ml - active: buprenorphine 100mg excipient: n-methyl-2-pyrrolidone polyglactin - sublocade is indicated for maintenance treatment of opioid dependence, within a framework of medical, social and psychological treatment.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine 300mg - injection (depot) - 300 mg/1.5ml - active: buprenorphine 300mg excipient: n-methyl-2-pyrrolidone polyglactin - sublocade is indicated for maintenance treatment of opioid dependence, within a framework of medical, social and psychological treatment.

Belgio - tedesco - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - tiamulin wasserstoff-fumarat - granulat zum eingeben über das trinkwasser - 450 mg/g - tiamulin wasserstoff-fumarat 450 mg/g - tiamulin - schwein; geflügel

Portogallo - portoghese - DGAV (Direção Geral de Alimentação e Veterinária)

hcs bvba - tiamulina 364.28 mg - granulado para administração na água de bebida e/ou ração - tiamulina - suínos

Svizzera - tedesco - OFAG-BLW (Bundesamt für Landwirtschaft)

basf france - propyzamide - 2120099 - frankreich - herbizid ;

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

krka d.d. novo mesto - tiamulinhydrogenfumarat til veterinær anvendelse - granulat til anvendelse i drikkevand - 450 mg/g - fjerkræ, svin

Unione Europea - polacco - EMA (European Medicines Agency)

merck sharp dohme limited - siarczan vorapaksaru - zawał mięśnia sercowego - Środki przeciwzakrzepowe - zontivityis wykazano, aby zmniejszyć aterotrombotičeskih zdarzeń u dorosłych pacjentów z historią zawału mięśnia sercowego (im)wprowadzone w połączeniu z kwas acetylosalicylowy (asa) i, w razie potrzeby, klopidogrel; lub - objawem choroby tętnic obwodowych(zpa), wprowadzone w połączeniu z kwas acetylosalicylowy (asa) lub, w razie potrzeby, klopidogrel.